Patients across GM and the UK, will have greater access to cutting-edge treatments and clinical trials following a government announcement of £100m of private investment to set up local research hubs.

Our patients are regularly the first-in-the-world to have the opportunity to trial new treatments, and even more are first in the UK. Research and innovation are key to achieving our vision to be ...

The Pharmacogenetics Roll Out – Gauging Response to Service [PROGRESS] programme is an NHS England funded transformation project led by researchers at Manchester University NHS Foundation Trust.

We care for over one million patients each year, and manage over 800 clinical research studies at any one time. Through our Research and Innovation Division, supported by the National Institute for ...

Research and Innovation is made up of multi-disciplinary staff ranging from research governance to research support services such as labs and imaging.

North Manchester General Hospital is now part of the wider family of MFT hospitals creating a Single Hospital Service for Manchester. Manchester Royal Infirmary is a large teaching hospital and ...

The Research and Innovation (R&I) Annual Report for 2023 – 2024: Delivering Change Together (covering 1 April 2023 to 31 March 2024) details the scope and breadth of R&I at Manchester University NHS ...

Recently the National Institute for Health and Care Research (NIHR) Manchester Biomedical Research Centre (BRC) and the NIHR North West Regional Research Delivery Network collaboratively hosted the ...

New research at Wythenshawe Hospital, has the potential to limit the development of antibiotic resistance while improving patient outcomes, when treating very ill patients with pneumonia and sepsis.

Wythenshawe Hospital is a major teaching hospital for the region and hosts a broad portfolio of research, in collaboration with The University of Manchester. Research across the hospital is focused on ...